Development of Self-assembled Nanoceramic Carrier Construct(s) for Vaccine Delivery

Abstract

Hydroxyapatite (HA) has been extensively investigated as scaffolds for tissue engineering, as drug delivery agents, as non-viral gene carriers, as prosthetic coatings, and composites. Recent studies in our laboratory demonstrated the immunoadjuvant properties of HA when administered with malarial merozoite surface protein-1₁₉ (MSP-1₁₉). HA nanoceramic carrier was prepared by co-precipitation method that comprises of sintering and spray-drying technique. Prepared systems were characterized for crystallinity, size, shape, and antigen loading efficiency. Small size and large surface area of prepared HA demonstrated good adsorption efficiency of immunogens. Prepared nanoceramic formulations also showed slower in vitro antigen release and slower biodegrability behavior, which may lead to a prolonged exposure to antigen-presenting cells and lymphocytes. Furthermore, addition of mannose in nanoceramic formulation may additionally lead to increased stability and immunological reactions. Immunization with MSP-1₁₉ in nanoceramic-based adjuvant systems induced a vigorous immunoglobulin G (IgG) response, with higher IgG2a than IgG1 titers. In addition considerable amount of IFN-g and IL-2 was observed in spleen cells of mice immunized with nanoceramic-based vaccines. On the contrary, mice immunized with MSP-1₁₉ alone or with alum did not exhibit a significant cytotoxic response. The antibody responses to vaccine co-administered with HA was a mixed Th1/Th2 compared to the Th2-biased response obtained with alum. The prepared HA nanoparticles exhibit physicochemical properties that appear promising to make them a suitable immunoadjuvant to be used as antigen carriers for immunopotentiation.

Keywords

hydroxyapatite nanoparticles malaria vaccines drug delivery.

Get full access to this article

View all access options for this article.

References

Storni, T. , Kundig, T.M. , Senti, G. and Johansen, P. (2005). Immunity in Response to Particulate Antigen-delivery Systems, Adv. Drug Del. Rev., 57: 333-355.

Brennan, F.R. and Dougan, G. (2005). Non-clinical Safety Evaluation of Novel Vaccines and Adjuvants: New Products, New Strategies, Vaccine, 23: 3210-3222.

O'Hagan, D.T. , MacKichan, M.L. and Singh, M. (2001). Recent Developments in Adjuvants for Vaccines Against Infectious Diseases , Biomol. Eng., 18: 69-85.

Olton, D. , Li, J. , Wilson, M.E. , Rogers, T. , Close, J. , Huang, L. , Kumta, P.N. and Sfeir, C. (2007). Nanostructured Calcium Phosphates (NanoCaPs) for Non-viral Gene Delivery: Influence of the Synthesis Parameters on Transfection Efficiency, Biomaterials, 28: 1267-1279.

Doonan, S. (2004). Chromatography on Hydroxyapatite, Methods Mol. Biol., 244: 191-194.

Ueno, Y. , Futagawa, H. , Takagi, Y. , Ueno, A. and Mizushim, Y. (2005). Drug-incorporating Calcium Carbonate Nanoparticles for a New Delivery System, J. Control Rel., 103: 93-98.

Wassell, D.T.H. , Hall, R.C. and Embery, G. (1995). Adsorption of BSA onto Hydroxyapatite, Biomaterials, 16: 697-702.

Kandori, K. , Miyagawa, K. and Ishikawa, T. (2004). Adsorption of Gamma Immuno Globulin onto Various Synthetic Calcium Hydroxyapatite Particles, J. Colloid Interf. Sci., 273: 406-413.

Matsumoto, T. , Okazaki, M. , Inoue , M. , Yamaguchi, S. , Kusunose, T. , Toyonaga, T. , Hamada, Y. and Takahashi, J. (2004). Hydroxyapatite Particles as a Controlled Release Carrier of Protein, Biomaterials, 25: 3807-3812.

10.

Luo, Q. and Andrade, J.D. (1998). Cooperative Adsorption of Proteins onto Hydroxyapatite , J. Colloid Interf. Sci., 200: 104-113.

11.

Gorbunoff, M.J. (1984). The Interaction of Proteins with Hydroxyapatite, Anal. Biochem., 136: 425-432.

12.

Paul, W. and Sharma, C.P. (2003). Ceramic Drug Delivery: A Perspective, J. Biomater. Appl., 17: 253-264.

13.

Lindblad, E.B. (2004). Aluminium Compounds for use in Vaccines, Immunol. Cell Biol., 82: 497-505.

14.

Gupta, R.K. , Rost, B.E. , Relyveld, E. and Siber, G.R. (1995). Adjuvant Properties of Aluminum and Calcium Compounds , In: Powell, M.F. and Newman, M.J. (eds), Vaccine Design: The Subunit and Adjuvant Approach, pp. 229-248, Plenum Press, New York.

15.

Pham, H.N. , Luo, P. , Genin, F. and Dash, A.K. (2002). Synthesis and Characterization of Hydroxyapatite-ciprofloxacin Delivery Systems by Precipitation and Spray Drying Technique, AAPS Pharm. Sci. Tech., 3: E1-E7.

16.

Tas, A.C. (2001). X-ray Diffraction Data for Flux Grown Calcium Hydroxyapatite Whiskers, Powder Diffr. , 16: 102-106.

17.

Mizushima, Y. , Ikoma, T. , Tanaka , J. , Hoshi, K. , Ishihara, T. , Ogawa, Y. and Ueno, A. (2006). Injectable Porous Hydroxyapatite Microparticles as a New Carrier for Protein and Lipophilic Drugs, J. Control Rel., 110: 260-265.

18.

Dias, A.G. , Lopes, M.A. and Santos, J.D. (2006). In Vivo Performance of Biodegradable Calcium Phosphate Glass Ceramics using the Rabbit Model: Histological and Sem Observation, J. Biomater. Appl., 20: 253-266.

19.

Sachdeva, S. , Ahmad, G. , Malhotra , P. , Mukherjee, P. and Chauhan, V.S. (2004). Comparison of Immunogenicities of Recombinant Plasmodium Vivax Merozoite Surface Protein 119 and 42 kilodalton Fragments Expressed in Escherichia coli, Infect . Immun., 70(10): 5775-5785.

20.

Saifuddin, M. , Hart, M.L. , Gewurz , H. , Zhang, Y. and Spear, G.T. (2000). Interaction of Mannose-binding Lectin with Primary Isolates of Human Immunodeficiency Virus Type 1, J. Gen. Virol., 81: 949-955.

21.

Hegde, V.L. and Venkatesh, Y.P. (2007). Generation of Antibodies Specific to D-mannitol, a Unique Haptenic Allergen, using Reductively Aminated D-mannose-bovine Serum Albumin Conjugate as the Immunogen Immunobiol, 212: 119-128.

22.

Banchereau, J. , Briere, F. , Caux , C. , Davoust, J. , Lebecque, S. , Liu , Y. , Pulendran, B. and Palucka, K. (2000). Immunobiology of Dendritic Cells, Annu. Rev. Immunol., 8: 767-811.